Sunir J. Garg, MD, is Professor of Ophthalmology at the Retina Service of Wills Eye Hospital, Thomas Jefferson University, and is a partner with Mid Atlantic Retina. He is co-director of the Retina Research Unit at Wills Eye Hospital. He has published more than 400 peer reviewed papers, book chapters, and commentaries, and is editor of ophthalmology for the Merck Manual, Deputy Editor in Chief of the American Academy of Ophthalmology ONE Network, outgoing Editor-in-Chief of Retina Times, and a member of the Editorial Boards of the American Journal of Ophthalmology and the Canadian Journal of Ophthalmology. He is also an official clinical spokesperson for the American Academy of Ophthalmology.
Dr. Garg has been featured in the Wall Street Journal, USA Today, the Philadelphia Inquirer, Popular Science, The Atlantic, Women’s Health, and has been on Good Morning America, the Today Show, and the Canadian Broadcasting Corporation.
Financial disclosure: Dr. Garg has/had an affiliation (financial or otherwise) with a commercial organization:
- Apellis
- Bausch & Lomb
- Boehringer lngelheim
- Coherus
- Genentech
- Kanaph
- Kodiak Biosciences
- Merck Manual
- NGM Bio
- Regeneron
Sessions in which Sunir J. Garg, MD, FACS, FASRS participates
Sunday 12 June, 2022
LEARNING OBJECTIVESAt the end of this symposium, participants will be able to:Identify the critical unmet needs in neovascular AMD and DME managementDemonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME managementExamine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DMEApply new insights from multi-modal imagin...
